La inteligencia artificial (IA) está transformando cada fase de la gestión de desastres naturales, desde la mitigación y la prevención hasta la respuesta y la recuperación, permitiendo predicciones más precisas y acciones más rápidas. …
La Inteligencia Artificial en la gestión de desastres naturales Read More »
El ajedrez exige habilidades de memoria de trabajo, razonamiento espacial y toma de decisiones bajo incertidumbre, convirtiéndolo en un excelente modelo para estudiar el pensamiento de alto nivel. Estudios pioneros en fMRI han comparado la actividad cerebral al analizar posiciones de ajedrez …
Entretejido de jugadas y neuronas: Cómo el ajedrez ilumina la ciencia Read More »
At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a radiopharmaceuticals market that could top $16 billion by 2033.
Radiopharma Powerhouses Push Frontiers With New Indications, Innovation Read More »
As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are targeting the next goalpost: a cure.
Biopharma Targets an HIV Cure as NIH Funding Cuts Threaten To Derail Progress Read More »
To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of protein aggregates in the brain.
Bringing Neurological Disease Into the Age of Precision Medicine Read More »
Ebekozien, chief quality officer of the American Diabetes Association, said the nonprofit is seeing a shift with more devices authorized for Type 2 diabetes.
ADA’s Osagie Ebekozien on diabetes tech for Type 2, new CGM standards Read More »
The health system said the cuts were motivated by “macroeconomic realities and anticipated challenges ahead.”
The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.
The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.
A quickly evolving political landscape and challenges to reliable revenue streams led major for-profit providers to exercise restraint and reaffirm their 2025 outlooks.
Providers keep 2025 outlooks in place amid uncertain operating landscape Read More »
